Thermo Fisher Scientific Inc. (LON:0R0H)
| Market Cap | 163.34B |
| Revenue (ttm) | 32.61B |
| Net Income (ttm) | 4.90B |
| Shares Out | n/a |
| EPS (ttm) | 12.91 |
| PE Ratio | 33.34 |
| Forward PE | 23.78 |
| Dividend | 1.27 (0.22%) |
| Ex-Dividend Date | Sep 15, 2025 |
| Volume | 2,294 |
| Average Volume | 1,967 |
| Open | 561.00 |
| Previous Close | 564.81 |
| Day's Range | 557.00 - 576.98 |
| 52-Week Range | 385.88 - 609.45 |
| Beta | 0.91 |
| RSI | 64.98 |
| Earnings Date | Jan 29, 2026 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar... [Read more]
Financial Performance
In 2024, Thermo Fisher Scientific's revenue was $42.88 billion, an increase of 0.05% compared to the previous year's $42.86 billion. Earnings were $6.34 billion, an increase of 5.67%.
Financial numbers in USD Financial StatementsNews
Thermo Fisher (TMO) Announces $5 Billion Share Buyback Plan
Thermo Fisher (TMO) Announces $5 Billion Share Buyback Plan
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact(edit)
Thermo Fisher Unveils $5 Billion Buyback, Keeps Dividend Intact(edit)
Thermo Fisher Scientific (TMO) Announces $5B Share Buyback
Thermo Fisher Scientific (TMO) Announces $5B Share Buyback
Thermo Fisher Scientific (TMO) Approves $5 Billion Share Buyback
Thermo Fisher Scientific (TMO) Approves $5 Billion Share Buyback
Thermo Fisher authorizes $5B in share buybacks
Thermo Fisher Scientific authorizes $5B share repurchase program
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the repurchase of $5 billion...
Thermo Fisher Scientific Declares Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 20 Years
Thermo Fisher Scientific (NYSE: TMO) has outperformed the market over the past 20 years by 6.91% on an annualized basis producing an average annual return of 15.82%. Currently, Thermo Fisher Scientif...
Ball Corporation Navigates Aluminum Price Swings Confidently, Reaffirms Outlook
Ball Corporation (NYSE: BALL) on Tuesday reported third-quarter results that exceeded analyst expectations in revenue, while earnings were in line with market estimates. The company posted comparable...
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT Insight
See Which Of The Latest 13F Filers Holds TMO
At Holdings Channel, we have reviewed the latest batch of the 21 most recent 13F filings for the 09/30/2025 reporting period, and noticed that Thermo Fisher Scientific Inc (Symbol: TMO) was held by 11...
How Is The Market Feeling About Thermo Fisher Scientific Inc?
Thermo Fisher Scientific Inc's (NYSE: TMO) short interest as a percent of float has fallen 7.96% since its last report. According to exchange reported data, there are now 3.91 million shares sold sho...
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities
Thermo Fisher Scientific (NYSE: TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and oth...
Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities
Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other...
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion, strengthening its clinical trial research business amid a strong rebound in demand in...
First Look: Thermo Fisher Eyes $10B Clario Deal
First Look: Thermo Fisher Eyes $10B Clario Deal
Thermo Fisher Scientific (TMO) Announces Acquisition of Clario Holdings for $8.875 Billion
Thermo Fisher Scientific (TMO) Announces Acquisition of Clario Holdings for $8.875 Billion
If You Invested $1000 in Thermo Fisher Scientific a Decade Ago, This is How Much It'd Be Worth Now
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Thermo Fisher (TMO) to Acquire Clario for $8.875 Billion
Thermo Fisher (TMO) to Acquire Clario for $8.875 Billion
Thermo Fisher (TMO) Set to Acquire Clario Holdings for $8.875 Billion
Thermo Fisher (TMO) Set to Acquire Clario Holdings for $8.875 Billion
Thermo Fisher (TMO) to Acquire Clario Holdings for $8.875 Billion
Thermo Fisher (TMO) to Acquire Clario Holdings for $8.875 Billion
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Sethi: Thermo Fisher is a world-class compounder you want in your portfolio
Sarat Sethi, Managing Partner at DCLA, highlights opportunities in undervalued sectors like healthcare and diagnostics, says trade clarity could boost growth, and calls Thermo Fisher a standout pick.
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion
Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for $8.88 billion in cash.